Effect of Magnesium Alginate in Infants With Gastroesophageal Reflux.

Policlinico Hospital89 enrolled

Overview

Recurrent regurgitation stress the infants and their parents and often results in an inappropirate use of PPI prescription in infancy. The aim of this study is to evaluate the efficacy of Mg alginate in infants with symptoms of gastroesophageal reflux.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Gastro Esophageal Reflux

Interventions

Mg alginateDIETARY_SUPPLEMENT

Mg alginate after feedings

Eligibility

Sex: ALLMin age: 3 WeeksMax age: 1 YearHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * symptoms suggestive of GER, evaluated through a validated questionnaire (Infant Gastroesophageal Reflux Questionnaire Revised: I-GERQ-R \> 16) * informed consent signed Exclusion Criteria: * congenital or chronic diseases * use of anti acid drugs

Locations (1)

Dept Of Obstetrics and Neonatology - Section of Neonatology University of Bari Policlinico Hospital

Bari, Italy

Outcomes

Primary Outcomes

Infant Gastro-Esophageal Reflux Questionnaire Revised

12-item validated questionnaire called Infant Gastro-Esophageal Reflux Questionnaire Revised (I-GERQ-R) which include different questions about regurgitation, crying, feeding and respiratory problems

Time frame: through study completion, an average of 1 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.